Anti-IL-2 receptor antibodies as models for cancer therapy (Record no. 78037)

000 -LEADER
fixed length control field 02004ngm a2200361 a 4500
001 - CONTROL NUMBER
control field HST1394_1_2
003 - CONTROL NUMBER IDENTIFIER
control field UkLoHST
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m c
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr|cna|||a||||
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field vz|czazum
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 080121s2007 enk|||||||||||s|||v|eng d
028 50 - PUBLISHER NUMBER
Publisher number 1394
Source Henry Stewart Talks
035 ## - SYSTEM CONTROL NUMBER
System control number (UkLoHST)587
035 ## - SYSTEM CONTROL NUMBER
System control number (UkLU-K)AC000392351
040 ## - CATALOGING SOURCE
Original cataloging agency UkLU-K
Language of cataloging eng
Transcribing agency UkLU-K
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Waldmann, Thomas,
Dates associated with a name 1930-
Relator code spk
245 10 - TITLE STATEMENT
Title Anti-IL-2 receptor antibodies as models for cancer therapy
Medium [electronic resource] /
Statement of responsibility, etc. Thomas A. Waldmann.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. London :
Name of publisher, distributor, etc. Henry Stewart Talks,
Date of publication, distribution, etc. 2007.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (1 streaming video file (45 min.) :
Other physical details color, sound).
490 1# - SERIES STATEMENT
Series statement Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances,
International Standard Serial Number 2056-452X
500 ## - GENERAL NOTE
General note Animated audio-visual presentation with synchronized narration.
500 ## - GENERAL NOTE
General note Title from title frames.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Contents: Structure and function of IL-2 receptor -- Disorders of IL-2 receptor expression in disease -- IL-2R alpha-directed monoclonal antibody mediated therapy of leukemia and autoimmune diseases -- Anti-IL-2E alpha monoclonals armed with toxins or radionuclides -- IL-15 and its use of the IL-/IL-15 beta receptor -- IL-2/IL-15 R beta receptor directed therapy for leukemia and autoimmune diseases -- The IL-2R alpha as a target in the elimination of CD4+ CD25+ T-regs (suppressor cells).
506 ## - RESTRICTIONS ON ACCESS NOTE
Terms governing access Access restricted to subscribers.
538 ## - SYSTEM DETAILS NOTE
System details note Mode of access: World Wide Web.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Antibodies, Monoclonal
General subdivision therapeutic use.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Autoimmune Diseases
General subdivision therapy.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Leukemia
General subdivision therapy.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Receptors, Interleukin-2.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Henry Stewart talks.
Name of part/section of a work Biomedical & life sciences collection.
-- Monoclonal antibodies as therapeutic agents : fundamentals, therapeutic applications and latest advances.
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/587/">https://hstalks.com/bs/587/</a>
856 42 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://hstalks.com/bs/p/30/">https://hstalks.com/bs/p/30/</a>
Materials specified Series

No items available.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571